SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- Protein Polymer Technologies,
Inc. (OTC Bulletin Board: PPTI), announced today that Donald Kaplan, Ph.D.,
President and Chief Operating Officer of PPTI, will present a Company update
at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference being held
at The New York Palace Hotel in New York on November 7 - 9, 2005.
Dr. Kaplan is scheduled to speak on Wednesday, November 9, 2005 at
12:20 p.m. Eastern Time. A live webcast of the presentation can be accessed
at http://wsw.com/webcast/rrshq7/ppti.ob/ and through the Company's website at
http://www.ppti.com. The presentation will be archived for a limited time.
About Protein Polymer Technologies, Inc.
Protein Polymer Technologies, Inc. is a biotechnology company that
discovers and develops innovative therapeutic devices to improve medical and
surgical outcomes. The Company focuses on developing technology and products
to be used for soft tissue augmentation, tissue adhesives and sealants, wound
healing support and drug delivery devices. Protein Polymer Technologies'
proprietary protein-based biomaterials are uniquely tailored to optimize
clinical performance and contain no human or animal components that could
potentially transmit or cause disease. The company is headquartered in San
Diego, California. For additional information about the company, please visit
http://www.ppti.com.
To date, PPTI has been issued twenty-six U.S. Patents on its core
technology with corresponding issued and pending patents in key international
markets.
This press release contains forward-looking statements that are based on
management's views and expectations. Actual results could differ materially
from those expressed here; further, the Company is not obligated to comment
specifically on those differences. Risks associated with the Company's
activities include raising adequate capital to continue operations scientific
and product development uncertainties, competitive products and approaches,
continuing collaborative partnership interest and funding, regulatory testing
and approvals, and manufacturing scale up. The reader is encouraged to refer
to the Company's 2004 Annual Report Form 10-KSB, and 10KSB/A and other recent
filings with the Securities and Exchange Commission, copies of which are
available from the Company, to further ascertain the risks associated with the
above statements.
SOURCE Protein Polymer Technologies
 back to top
Related links:
http://www.ppti.com
Audio:http://wsw.com/webcast/rrshq7/ppti.ob
CONTACT:
Investor Contact: Erin Davis, of Protein
Polymer Technologies, Inc., +1-858-558-6064 x 120; or Media
Contact: Bryan deCastro, +1-631-495- 9177; or Carole Boucard,
+1-954-370-2524, both of Creative Public Relations
|
